A step forward in therapy for ALL in infants

Lancet

Volumn 370, Issue 9583, 2007, Pages 198-200

  Ribera, Josep Maria ^a   Oriol, Albert ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; DRUG MEGADOSE; HUMAN; INFANT; INFANT DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 34447570646     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61101-5     Document Type: Note

References (12)

1. Pui C., and Evans W. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
2. Pieters R., Schrappe M., De Lorenzo P., et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370 (2007) 240-250
3. Mann G., Cazzaniga G., van der Velden V., et al. Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: the big sister of the infant disease?. Leukemia 21 (2007) 642-646
4. Jansen M., Corral L., van der Velden V., et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 21 (2007) 633-641
5. Balduzzi A., Valsecchi M., Uderzo C., et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first remission: comparison by genetic randomisation in an international prospective study. Lancet 366 (2005) 635-642
6. Ribera J., Ortega J., Oriol A., et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for children with very high-risk acute lymphoblastic leukemia: results of the PETHEMA ALL-93 trial. J Clin Oncol 25 (2007) 16-24
7. Sanders J., Joon Im H., Hoffmeister P., et al. Allogeneic hematopoietic stem cell transplantation for infants with acute lymphoblasic leukemia. Blood 105 (2005) 3749-3756
8. Pui C., Gaynon P., Boyett J., et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements in the 11q23 chromosomal region. Lancet 359 (2002) 1909-1915
9. Satwani P., Sather H., Ozkaynak F., et al. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: a Children's Oncology Group Study report. Biol Bone Marrow Transplant 13 (2007) 218-227
10. Inukai T., Zhang X., Goto M., et al. Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity. Leukemia 20 (2006) 2119-2129
11. Thompson P., Murry D., Rosner G., et al. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 59 (2007) 847-853
12. Stam R., den Boer M., and Pieters R. Toward targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol 132 (2006) 539-551